Teva to buy Allergan's generics biz
July 27, 2015 at 05:27 AM EDT
Israel's Teva Pharmaceutical to buy Allergan's generic pharmaceuticals business for $40.5 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.